Companion Diagnostics Market Size, Share, By Offerings (Products and Services), Technology (Polymerase Chain Reaction (PCR), Next-generation Sequencing (NGS), Immunohistochemistry (IHC), Fluorescence In Situ Hybridization (FISH), and, Others), Therapeutic Area (Oncology, Immunology, Neurology, Autoimmune, Cardiovascular, Infectious Disease, and Others), End-User (Pharmaceutical & Biotechnological Companies, Contract Research Laboratories, Diagnostics Laboratories, and Others), and Region - Trends, Analysis, and Forecast till 2035

Based on geography, the companion diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. 

North America is the dominating region for the companion diagnostics market due to advancement in healthcare infrastructure, strong emphasis on precision medicine initiatives, and presence of pharmaceutical & biotechnology companies in this region, and rapid adoption of new diagnostics technologies help to drive companion diagnostics market in North America region.

Asia Pacific is expected to be fastest-growing region in the target market, as the increased cancer incidence, technological advancements and focus on precision medicine. Rising investments in healthcare infrastructure, encouraging legal framework and rising funding for the research & development, is expected to drive companion diagnostics market in upcoming years.